Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Videoendoscopic Drainage of Infected Pancreatic Collections

This study has been completed.
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Identifier:
First received: May 22, 2003
Last updated: January 12, 2010
Last verified: January 2010

The VARD (Videoendoscopic Assisted Retroperitoneal Drainage) approach as treatment for necrotizing pancreatitis proposes an alternative to standard complicated open abdomen treatment methods.

This treatment involves making a small incision and looking inside the abdomen with a videoendoscope. A videoendoscope is an instrument with a small camera and light on the end. It also has an extension tool that the surgeon can use to clean out any dead and infected tissue in the abdomen.

This approach may reveal a treatment opportunity with faster recovery potential and shorter hospitalizations for patients with necrotizing pancreatitis.

Condition Intervention Phase
Pancreatitis, Acute Necrotizing
Procedure: Videoscopic-Assisted Retroperitoneal Debridement (VARD)
Phase 2

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Estimated Enrollment: 40
Study Start Date: September 2003

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
  • Pancreatic necrosis or peripancreatic fluid collection following acute pancreatitis noted on CT scan
  • Infected pancreatic necrosis or pancreatic abscess and determined by + FNA (gram stain or culture), as defined by the Atlanta Symposium
  • Not neutropenic or pregnant
  • No prior necrosectomy
  • No pancreatic pseudocyst, either sterile or infected
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00061269

United States, Oregon
Oregon Health Sciences University
Portland, Oregon, United States, 97239
Veteran's Administration-Portland
Portland, Oregon, United States, 97239
United States, Washington
Harborview Medical Center
Seattle, Washington, United States, 98104
University of Washington
Seattle, Washington, United States, 98195
Veteran's Administration Puget Sound
Seattle, Washington, United States, 98108
Canada, Ontario
University of Toronto
Toronto, Ontario, Canada
Sponsors and Collaborators
  More Information

No publications provided Identifier: NCT00061269     History of Changes
Other Study ID Numbers: VDIPC (completed)
Study First Received: May 22, 2003
Last Updated: January 12, 2010
Health Authority: United States: Federal Government

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
Infected pancreatic necrosis

Additional relevant MeSH terms:
Pancreatitis, Acute Necrotizing
Digestive System Diseases
Pancreatic Diseases processed this record on November 25, 2014